title: The potential role of aprotinin in the perioperative management of malignant tumors.
authors.affiliation: Department of Thoracic and Cardiovascular Surgery, The University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Boulevard, Box 445, Houston, TX 77030, USA.
authors.forename: Ara A
authors.initials: AA
authors.lastname: Vaporciyan
authors.forename: Joe B
authors.initials: JB
authors.lastname: Putnam
authors.forename: W Roy
authors.initials: WR
authors.lastname: Smythe
mesh_terms: D000818:Animals; D007611:Aprotinin / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D016063:Blood Loss, Surgical / Q000517:prevention & control; D018450:Disease Progression; D005260:Female; D006487:Hemostasis; D006801:Humans; D007610:Kallikreins / Q000502:physiology; D007668:Kidney / Q000187:drug effects; D008577:Meningeal Neoplasms / Q000601:surgery; D008579:Meningioma / Q000601:surgery; D008654:Mesothelioma / Q000601:surgery; D009361:Neoplasm Invasiveness; D009362:Neoplasm Metastasis / Q000517:prevention & control; D009369:Neoplasms / Q000188:drug therapy* / Q000503:physiopathology; D009389:Neovascularization, Pathologic / Q000503:physiopathology; D010051:Ovarian Neoplasms / Q000503:physiopathology; D011013:Pneumonectomy; D012509:Sarcoma / Q000601:surgery; D015842:Serine Proteinase Inhibitors / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D001749:Urinary Bladder Neoplasms / Q000601:surgery; D014568:Urokinase-Type Plasminogen Activator / Q000037:antagonists & inhibitors
chemical_list: D015842:Serine Proteinase Inhibitors; D007611:Aprotinin; D007610:Kallikreins; D014568:Urokinase-Type Plasminogen Activator